The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial
Titel:
The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial
Auteur:
Swaminathan, Mahesh Kantarjian, Hagop Daver, Naval Borthakur, Gautam Ohanian, Maro Kadia, Tapan DiNardo, Courtney Jain, Nitin Estrov, Zeev Ferrajoli, Alessandra Garcia-Manero, Guillermo Konopleva, Marina Andreeff, Michael Pemmaraju, Naveen Jabbour, Elias Alvarado, Yesid Wierda, William Pinsoy, Maria Rhona Ravandi, Farhad Cortes, Jorge